A research group consisting of Professor Masahiro Nishibori (Specially Appointed Professor）, Department of Translational Research and Drug Development, Faculty of Medicine, Dentistry and ...
Healthy newborn infants rarely Buffer from thrombosis, despite their low plasma antithrombin III (ATIII) levels. In adults, ATIII is the main inhibitor of thrombin; α 2-macroglobulin (α 2 M) and ...
The study was approved by the Ethics Committee (Krakow District Medical Chamber, Poland; 26/KBL/OIL/2011), and all participants gave written informed consent in compliance with the Declaration of ...
BERLIN, GERMANY — An investigational RNA interference (RNAi) agent that reduces levels of circulating antithrombin promotes clotting function in people with hemophilia A or B [1]. By depleting ...
The FDA has approved the storage of Thrombate III (antithrombin III [human], from Talecris Biotherapeutics) under room temperature conditions less than or equal to 25ºC (77ºF). Thrombate III is a ...
BOSTON, Mass., July 16, 2009– Data presented at the annual meeting of the International Society on Thrombosis and Haemostasis (ISTH) in Boston show that ATryn® (Antithrombin [Recombinant]) safely ...
The Case: A previously healthy 24-year-old man presented to the emergency department with sudden onset of severe periumbilical and right costovertebral pain accompanied by nausea and vomiting. His ...
Thrombate III is the only antithrombin concentrate approved in both adult and pediatric patients for hereditary antithrombin deficiency. The Food and Drug Administration (FDA) has expanded the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results